IMNM
Price
$18.57
Change
-$1.11 (-5.64%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
2.1B
75 days until earnings call
Intraday BUY SELL Signals
ZVRA
Price
$10.61
Change
-$0.56 (-5.01%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
627.21M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs ZVRA

Header iconIMNM vs ZVRA Comparison
Open Charts IMNM vs ZVRABanner chart's image
IMNM vs ZVRA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMNM vs. ZVRA commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and ZVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2026
Stock price -- (IMNM: $19.68 vs. ZVRA: $11.18)
Brand notoriety: IMNM and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 78% vs. ZVRA: 70%
Market capitalization -- IMNM: $2.1B vs. ZVRA: $627.21M
IMNM [@Biotechnology] is valued at $2.1B. ZVRA’s [@Biotechnology] market capitalization is $627.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.41B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while ZVRA’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 6 bearish.
  • ZVRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZVRA is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -12.69% price change this week, while ZVRA (@Biotechnology) price change was -1.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.91%. For the same industry, the average monthly price growth was -7.91%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 19, 2026.

ZVRA is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-7.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.1B) has a higher market cap than ZVRA($627M). ZVRA YTD gains are higher at: 18.415 vs. IMNM (-13.571). ZVRA has higher annual earnings (EBITDA): 144M vs. IMNM (-231.45M). IMNM has more cash in the bank: 273M vs. ZVRA (201M). ZVRA has less debt than IMNM: ZVRA (1.15M) vs IMNM (4.01M). ZVRA has higher revenues than IMNM: ZVRA (122M) vs IMNM (9.68M).
IMNMZVRAIMNM / ZVRA
Capitalization2.1B627M335%
EBITDA-231.45M144M-161%
Gain YTD-13.57118.415-74%
P/E RatioN/A5.28-
Revenue9.68M122M8%
Total Cash273M201M136%
Total Debt4.01M1.15M350%
FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMZVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
ZVRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ERY11.390.44
+4.02%
Direxion Daily Energy Bear 2X ETF
RQI13.530.21
+1.58%
COHEN & STEERS QUALITY Income REALTY FUND
ZAPR26.55-0.08
-0.28%
Innovator Equity Dfnd Prt ETF -1 Yr Apr
BOCT52.34-0.69
-1.30%
Innovator U.S. Equity Buffer ETF™ Oct
SMCX23.22-6.73
-22.47%
Defiance Daily Target 2X Long SMCI ETF

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-5.67%
KURA - IMNM
50%
Loosely correlated
-0.34%
KYTX - IMNM
45%
Loosely correlated
-6.29%
NRIX - IMNM
44%
Loosely correlated
-4.25%
RLAY - IMNM
44%
Loosely correlated
-7.02%
VYGR - IMNM
44%
Loosely correlated
-8.29%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with XERS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-5.01%
XERS - ZVRA
36%
Loosely correlated
+0.49%
SPRO - ZVRA
34%
Loosely correlated
-5.37%
AXON - ZVRA
33%
Loosely correlated
-5.28%
IMNM - ZVRA
33%
Loosely correlated
-5.67%
GOSS - ZVRA
33%
Poorly correlated
-1.57%
More